Enduring Cognitive Deficits and Cortical Dopamine Dysfunction in Monkeys After Long-Term Administration of Phencyclidine
Authors:
- 15 August 1997
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 277 (5328) , 953-955
Abstract
The effects of the psychotomimetic drug phencyclidine on the neurochemistry and function of the prefrontal cortex in vervet monkeys were investigated. Monkeys treated with phencyclidine twice a day for 14 days displayed performance deficits on a task that was sensitive to prefrontal cortex function; the deficits were ameliorated by the atypical antipsychotic drug clozapine. Repeated exposure to phencyclidine caused a reduction in both basal and evoked dopamine utilization in the dorsolateral prefrontal cortex, a brain region that has long been associated with cognitive function. Behavioral deficits and decreased dopamine utilization remained after phencyclidine treatment was stopped, an indication that these effects were not simply due to direct drug effects. The data suggest that repeated administration of phencyclidine in monkeys may be useful for studying psychiatric disorders associated with cognitive dysfunction and dopamine hypofunction in the prefrontal cortex, particularly schizophrenia.Keywords
This publication has 33 references indexed in Scilit:
- Relations between neuropsychological performance and brain morphological and physiological measures in monozygotic twins discordant for schizophreniaPsychiatry Research: Neuroimaging, 1994
- Preferential activation of dopamine overflow in prefrontal cortex produced by chronic clozapine treatmentNeuroscience Letters, 1994
- Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's diseaseBrain, 1993
- The Effect of Clozapine on Cognition and Psychiatric Symptoms in Patients with SchizophreniaThe British Journal of Psychiatry, 1993
- Can the neuropsychological case-study approach be applied to schizophrenia?Psychological Medicine, 1991
- MPTP reduces dopamine and norepinephrine concentrations in the supplementary motor area and cingulate cortex of the primateNeuroscience Letters, 1990
- COGNITIVE AND MOTOR DEFICITS IN THE ACQUISITION OF AN OBJECT RETRIEVAL/DETOUR TASK IN MPTP-TREATED MONKEYSBrain, 1990
- Partial improvement in negative schizophrenic symptoms after amphetaminePsychopharmacology, 1982
- Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus MonkeyScience, 1979
- The performance of young schizophrenics and young normals on the Wisconsin Card Sorting Test.Journal of Consulting Psychology, 1951